Back to search
Pediatric Acute-Onset Neuropsychiatric Syndrome
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Pediatric Acute-Onset Neuropsychiatric Syndrome trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Pediatric Acute-Onset Neuropsychiatric Syndrome trials you may qualify forThe purpose of this study is to systematically evaluate the results of medical investigations to identify symptom and biological patterns and common etiologies…
The objective of the Pediatric Epidemiological Data and Incidence (PEDI) PANDAS study is to demonstrate the feasibility of enrollment and retention of subjects…
The unhide® Project is a non-interventional, longitudinal research study designed to establish a secure data repository of demographic, health, and lifestyle in…
We enroll pediatric patients who were diagnosed COVID-19 for main observation target. We will perform brain MRI and neuropsychiatric evaluation 4-6 months after…
This study is an investigation of the neurologic, immunologic, and rheumatologic markers of Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS). PANS is a co…
Open-label prospective trial to study efficacy, safety and tolerability of intravenous immunoglobulin (IVIG) once monthly for 6 months in children and adolescen…
A Superiority Study To Compare The Effect of Panzyga Versus Placebo in Patients with Pediatric Acute-onset Neuropsychiatric Syndrome
The Economic Impact Study of IVIG treatment for PANS is a part of the Unhide™ Project, which is a research initiative developed by the Brain Inflammation Collab…